The Islet Research group led by Dr. Aart van Apeldoorn focuses on developing improved beta cell delivery strategies for type 1 diabetes. His group aims to find and engineer an optimal islet transplantation environment using a combination of bioengineering, biomaterials science, tissue engineering and regenerative medicine research. His research involves developing technologies for pancreatic tissue engineering, design and manufacturing of islet delivery devices, and basic research regarding the islet extracellular matrix and the addition of cell stress relieving factors to delivery devices.
Aart’s group is currently also involved in RegMed XB as a research leader for the type 1 diabetes moonshot project. For research news and a more detailed list of publications on beta cell replacement please visit: www.aartvanapeldoorn.com, or www.regmedxb.com.
The Dutch Diabetes Fund's work wouldn't be possible without the contributions of its sponsors and contributors. On October 23, the annual fundraising campaign kicks off and we're grateful for any support you can give us. Please visit the website of the Dutch Diabetes Fund for more information on how to donate.